AI-Powered mRNA Drug Discovery & Development Market Size, Share & Trends Analysis Distribution by Application (Prophylactic Vaccines, Therapeutic Vaccines, Protein Replacement Therapies, Gene Editing Support), Therapeutic Area (Infectious Diseases, Oncology, Rare Genetic Diseases, Cardiovascular & Metabolic Disorders), Technology Type (Sequence Optimization, Delivery Systems, Predictive Modeling, Manufacturing Optimization), End-User (Hospitals & Clinics, Research Organizations, Pharmaceutical Companies) and Segment Forecasts, 2025-2034

Report Id: 3006 Pages: 180 Last Updated: 31 July 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of AI-Powered mRNA Drug Discovery & Development Market -

AI-Powered mRNA Drug Discovery & Development Market by Application -

  • Prophylactic Vaccines
  • Therapeutic Vaccines
  • Protein Replacement Therapies
  • Gene Editing Support

AI-Driven mRNA Therapeutics Market

AI-Powered mRNA Drug Discovery & Development Market by Therapeutic Area-

  • Infectious Diseases
  • Oncology
  • Rare Genetic Diseases
  • Cardiovascular & Metabolic Disorders

AI-Powered mRNA Drug Discovery & Development Market by Technology Type -

  • Sequence Optimization
  • Delivery Systems
  • Predictive Modeling
  • Manufacturing Optimization

AI-Powered mRNA Drug Discovery & Development Market by End-User -

  • Hospitals & Clinics
  • Research Organizations
  • Pharmaceutical Companies

AI-Powered mRNA Drug Discovery & Development Market by Region-

North America-

  • The US
  • Canada

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global AI-Powered mRNA Drug Discovery & Development Market Snapshot

Chapter 4. Global AI-Powered mRNA Drug Discovery & Development Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on AI-Powered mRNA Drug Discovery & Development Market Industry Trends
4.10. Global AI-Powered mRNA Drug Discovery & Development Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034

Chapter 5. AI-Powered mRNA Drug Discovery & Development Market Segmentation 1: By Application, Estimates & Trend Analysis
5.1. Market Share by Application, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:

5.2.1. Prophylactic Vaccines
5.2.2. Therapeutic Vaccines
5.2.3. Protein Replacement Therapies
5.2.4. Gene Editing Support

Chapter 6. AI-Powered mRNA Drug Discovery & Development Market Segmentation 2: By Therapeutic Area, Estimates & Trend Analysis
6.1. Market Share by Therapeutic Area, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Therapeutic Area:

6.2.1. Infectious Diseases
6.2.2. Oncology
6.2.3. Rare Genetic Diseases
6.2.4. Cardiovascular & Metabolic Disorders

Chapter 7. AI-Powered mRNA Drug Discovery & Development Market Segmentation 3: By Technology Type, Estimates & Trend Analysis
7.1. Market Share by Technology Type, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology Type:

7.2.1. Sequence Optimization
7.2.2. Delivery Systems
7.2.3. Predictive Modeling
7.2.4. Manufacturing Optimization

Chapter 8. AI-Powered mRNA Drug Discovery & Development Market Segmentation 4: By End-User, Estimates & Trend Analysis
8.1. Market Share by End-User, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-User:

8.2.1. Hospitals & Clinics
8.2.2. Research Organizations
8.2.3. Pharmaceutical Companies

Chapter 9. AI-Powered mRNA Drug Discovery & Development Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global AI-Powered mRNA Drug Discovery & Development Market, Regional Snapshot 2024 & 2034
9.2. North America

9.2.1. North America AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

9.2.1.1. US
9.2.1.2. Canada

9.2.2. North America AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.3. North America AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
9.2.4. North America AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
9.2.5. North America AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034

9.3. Europe

9.3.1. Europe AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe

9.3.2. Europe AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.3. Europe AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
9.3.4. Europe AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
9.3.5. Europe AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034

9.4. Asia Pacific

9.4.1. Asia Pacific AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific

9.4.2. Asia Pacific AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.4.3. Asia Pacific AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
9.4.4. Asia Pacific AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
9.4.5. Asia Pacific AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034

9.5. Latin America

9.5.1. Latin America AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America

9.5.2. Latin America AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.3. Latin America AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
9.5.4. Latin America AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
9.5.5. Latin America AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034

9.6. Middle East & Africa

9.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa

9.6.2. Middle East & Africa AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.6.3. Middle East & Africa AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2021-2034
9.6.4. Middle East & Africa AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by Technology Type, 2021-2034
9.6.5. Middle East & Africa AI-Powered mRNA Drug Discovery & Development Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034

Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles

10.2.1. Moderna

10.2.1.1. Business Overview
10.2.1.2. Key Application/Service Overview
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy

10.2.2. CureVac
10.2.3. Nutcracker Therapeutics
10.2.4. Ethris
10.2.5. Baidu (LinearDesign)
10.2.6. IBM
10.2.7. DeepMind (Alphabet)
10.2.8. Anima Biotech
10.2.9. Translate Bio (Sanofi)

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
8544
Security Code field cannot be blank!

Frequently Asked Questions

AI-Powered mRNA Drug Discovery & Development Market Size is predicted to grow with a 24.7% CAGR during the forecast period for 2025-2034.

Moderna, BioNTech, CureVac, Nutcracker Therapeutics, Ethris, Baidu (LinearDesign), IBM, DeepMind (Alphabet), Anima Biotech, Translate Bio (Sanofi)

Application, Therapeutic Area, Technology Type and End-User are the key segments of the AI-Powered mRNA Drug Discovery & Development Market.

North America region is leading the AI-Powered mRNA Drug Discovery & Development Market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying